Regeneron Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic ma…
Biotechnology
US, Tarrytown [HQ]

Balance Sheet

15 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Assets
741.00 1,089.00 1,323.00 2,080.00 2,951.00 3,871.00 5,609.00 6,973.00 8,764.00 11,734.00 14,805.00 17,163.00 25,434.00 29,214.00 33,080.00
Current
425.00 720.00 913.00 1,620.00 2,252.00 2,506.00 3,383.00 3,913.00 5,596.00 7,959.00 10,558.00 12,753.00 20,520.00 22,064.00 19,479.00
Non Current
315.00 369.00 409.00 459.00 698.00 1,364.00 2,225.00 3,059.00 3,167.00 3,775.00 4,246.00 4,409.00 4,914.00 7,149.00 13,601.00
Liabilities
344.00 561.00 837.00 835.00 998.00 1,329.00 1,954.00 2,524.00 2,620.00 2,977.00 3,715.00 6,138.00 6,666.00 6,550.00 7,107.00
Current
93.00 61.00 402.00 118.00 262.00 620.00 760.00 980.00 967.00 1,352.00 1,790.00 2,806.00 3,451.00 3,849.00 3,423.00
Non Current
250.00 500.00 435.00 716.00 736.00 709.00 1,193.00 1,543.00 1,652.00 1,625.00 1,924.00 3,331.00 3,215.00 2,701.00 3,683.00
Equity
396.00 527.00 485.00 1,245.00 1,952.00 2,542.00 3,654.00 4,449.00 6,144.00 8,757.00 11,089.00 11,025.00 18,768.00 22,664.00 25,973.00
Stockholders' Equity
396.00 527.00 485.00 1,245.00 1,952.00 2,542.00 3,654.00 4,449.00 6,144.00 8,757.00 11,089.00 11,025.00 18,768.00 22,664.00 25,973.00
Retained Earnings
-941.00 -1,045.00 -1,267.00 -517.00 -92.00 255.00 852.00 1,748.00 2,946.00 5,254.00 7,379.00 10,893.00 18,968.00 23,306.00 27,260.00
Common Stock
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Preferred Stock
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Profit
-67.00 -104.00 -221.00 750.00 424.00 348.00 636.00 895.00 1,198.00 2,444.00 2,115.00 3,513.00 8,075.00 4,338.00 3,953.00
Dividends
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Minority Interest
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Stockholders' Equity
1,336.00 1,575.00 1,754.00 1,763.00 2,045.00 2,234.00 2,793.00 2,713.00 3,196.00 3,515.00 3,688.00 102.00 -173.00 -404.00 -1,206.00
Loss Other Compr. Income
1.00 -2.00 -1.00 -1.00 -1.00 52.00 8.00 -12.00 - - -12.00 21.00 29.00 -26.00 -238.00 -80.00
End of REGN's Analysis
CIK: 872589 CUSIP: 75886F107 ISIN: US75886F1075 LEI: - UEI: -
Secondary Listings
REGN has no secondary listings inside our databases.